A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock☆
British Journal of Anaesthesia · 2026-01 · 136 (1) · 107-116
DOI: 10.1016/j.bja.2025.07.092 ↗Kurz gefasst
Fachartikel in der Zeitschrift British Journal of Anaesthesia, 2026-01. Verfasst von Pieter H Sloos und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, location University of Amsterdam, Amsterdam, The Netherlands; Laboratory of Experimental Intensive Care and An…. Hauptthemen laut MEDLINE: ADAMTS13 Protein, Fibrinolysis, Shock, Traumatic, Blood Coagulation Disorders. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, CSL Behring LLC, Amsterdam University Fund.
Abstract (Originalsprache)
BACKGROUND: Trauma-induced coagulopathy with hyperfibrinolysis is associated with high mortality. The protease ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 motifs 13) is cleaved after tissue injury. We analysed the underlying mechanism of ADAMTS13 proteolytic cleavage and the effect of ADAMTS13 on trauma-induced hyperfibrinolysis. METHODS: Thirty-nine trauma patients with shock were stratified based on ADAMTS13 conformation. Mechanisms of ADAMTS13 cleavage were explored in vitro using blood from healthy volunteers. The role of ADAMTS13 in hyperfibrinolysis was examined using rotational thromboelastometry (ROTEM) and a fibrin formation assay. RESULTS: ADAMTS13 circulated in a truncated and hyperactive form in 23% of trauma patients in shock. Truncated ADAMTS13 was associated with a significant increase in hyperfibrinolysis (ROTEM FIBTEM maximum lysis 85 [62-100] vs 1 [0-7]%, P=0.002) and mortality (44% vs 3%, P=0.007) compared with patients with a closed ADAMTS13 conformation. In vitro, ADAMTS13 was cleaved at its distal self-regulating domains in the presence of tissue plasminogen activator and plasmin, which concentration-dependently increased ADAMTS13 activity. This activation was prevented by tranexamic acid. Hyperactivated ADAMTS13 was associated with hyperfibrinolysis by both ROTEM and fibrin formation assays compared with conditions where ADAMTS13 was inactivated. CONCLUSIONS: During trauma-induced shock, ADAMTS13 can circulate in a truncated and hyperactivated conformation, which is associated with hyperfibrinolysis and mortality. In vitro, tissue plasminogen activator and plasmin can truncate ADAMTS13, increasing its activity. Additionally, ADAMTS13 directly contributes to hyperfibrinolysis, and tranexamic acid can prevent ADAMTS13 degradation. INSTITUTIONAL ETHICAL REVIEW BOARD APPROVAL NUMBERS: NL58766.018.16, NL74188.018.20.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, location University of Amsterdam, Amsterdam, The Netherlands; Laboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, location University of Amsterdam, Amsterd…
- Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.
- Department of Intensive Care Medicine, location University of Amsterdam, Amsterdam, The Netherlands.
- Center for Experimental and Molecular Medicine, location University of Amsterdam, Amsterdam, The Netherlands.
- Oklahoma State University Center for Health Sciences, Department of Biochemistry and Microbiology, Tulsa, OK, USA.
- Oklahoma State University Center for Health Sciences, Department of Biochemistry and Microbiology, Tulsa, OK, USA; Versiti Blood Research Institute, Milwaukee, WI, USA.
Förderung
- NIGMS NIH HHS
- CSL Behring LLC
- Amsterdam University Fund
- National Institute of General Medical Sciences
- European Society of Anaesthesiology
- National Institutes of Health
- Research Foundation Flanders
Zitieren
APA
Sloos, P. H., Vermeersch, L., Roozendaal, D. S., Delmote, A. S., Veer, C. V., Momanyi, T. O., Miranda, F. Z., Muia, J., Tersteeg, C., Vanhoorelbeke, K., Juffermans, N. P., & Kleinveld, D. J. B. (2026). A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock☆. British Journal of Anaesthesia, 136(1), 107-116. https://doi.org/10.1016/j.bja.2025.07.092
Vancouver
Sloos PH, Vermeersch L, Roozendaal DS, Delmote AS, Veer CV, Momanyi TO, et al. A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock☆. British Journal of Anaesthesia. 2026;136(1):107-116. doi:10.1016/j.bja.2025.07.092
BibTeX
@article{Sloos2026,
author = {Sloos, Pieter H and Vermeersch, Lisa and Roozendaal, Daphne S and Delmote, Anne-Sophie and Veer, Cornelis van 't and Momanyi, Thomas O and Miranda, Frida Z and Muia, Joshua and Tersteeg, Claudia and Vanhoorelbeke, Karen and Juffermans, Nicole P and Kleinveld, Derek J B},
title = {A novel role for ADAMTS13 in hyperfibrinolysis after trauma-induced shock☆},
journal = {British Journal of Anaesthesia},
year = {2026},
volume = {136},
number = {1},
pages = {107--116},
doi = {10.1016/j.bja.2025.07.092}
}
EUVIMED